What must be done to tackle vaccine hesitancy and barriers to COVID-19 vaccination in migrants?

DOI PDF PDF 被引用文献2件
  • Alison F Crawshaw
    Migrant Health Research Group, Institute for Infection and Immunity, St George’s, University of London, SW17 0RE London, UK
  • Anna Deal
    Migrant Health Research Group, Institute for Infection and Immunity, St George’s, University of London, SW17 0RE London, UK
  • Kieran Rustage
    Migrant Health Research Group, Institute for Infection and Immunity, St George’s, University of London, SW17 0RE London, UK
  • Alice S Forster
    Department of Behavioural Science and Health, University College London, WC1E 6BT London, UK
  • Ines Campos-Matos
    Health Improvement Division, Public Health England, SE1 8UG London, UK and UCL Collaborative Centre for Inclusion Health, University College London, WC1E 6BT London, UK
  • Tushna Vandrevala
    Department of Psychology, Kingston University London, Kingston KT2 7LB, UK
  • Andrea Würz
    Disease Programmes (AW, AP, JK, CD, TN); Public Health Functions (JES), European Centre for Disease Prevention and Control, Stockholm SE-Solna, Sweden
  • Anastasia Pharris
    Disease Programmes (AW, AP, JK, CD, TN); Public Health Functions (JES), European Centre for Disease Prevention and Control, Stockholm SE-Solna, Sweden
  • Jonathan E Suk
    Disease Programmes (AW, AP, JK, CD, TN); Public Health Functions (JES), European Centre for Disease Prevention and Control, Stockholm SE-Solna, Sweden
  • John Kinsman
    Disease Programmes (AW, AP, JK, CD, TN); Public Health Functions (JES), European Centre for Disease Prevention and Control, Stockholm SE-Solna, Sweden
  • Charlotte Deogan
    Disease Programmes (AW, AP, JK, CD, TN); Public Health Functions (JES), European Centre for Disease Prevention and Control, Stockholm SE-Solna, Sweden
  • Anna Miller
    Policy & Advocacy Division, Doctors of the World UK, part of the Médicins du Monde network, E14 5AA London, UK
  • Silvia Declich
    National Centre for Global Health, Istituto Superiore di Sanità, 00161 Roma RM, Italy
  • Chris Greenaway
    Department of Medicine, McGill University Montreal, H3A 1A1 Quebec, Canada
  • Teymur Noori
    Disease Programmes (AW, AP, JK, CD, TN); Public Health Functions (JES), European Centre for Disease Prevention and Control, Stockholm SE-Solna, Sweden
  • Sally Hargreaves
    Migrant Health Research Group, Institute for Infection and Immunity, St George’s, University of London, SW17 0RE London, UK

抄録

<jats:p>Migrants have been disproportionately impacted by COVID-19 and emerging evidence suggests they may face barriers to COVID-19 vaccination. Participatory approaches and engagement strategies are urgently needed to strengthen uptake, alongside innovative delivery mechanisms and sharing of best practice, to ensure migrants are better consider within countries’ existing vaccine priority structures.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ